– CNBC
JP Morgan Maintains Neutral on Enviva, Lowers Price Target to $60
JP Morgan analyst Mark Strouse maintains Enviva (NYSE:EVA) with a Neutral and lowers the price target from $66 to $60.
CNBC Halftime Report Final Trades: Intuitive Surgical, Ardagh Metal Packaging, A.O. Smith Corporation
– CNBC
Related Posts
$9,700 And Sliding Into Oprah’s DMs Helped This 31-Year-Old CEO Disrupt A $200B Industry
This story is part of a new series of features on the subject of success, Benzinga Inspire.
Jim Cramer Eats His Words On Palantir: Not A ‘Real Company’ A Month Ago, Now He’s High On Profitability, Says Russia Should ‘Look Out’
In early April, Jim Cramer picked Palantir Technologies Inc (NYSE: PLTR) apart, saying it's not even a "real company." One month later, he has completely
Are You An American Indian Or Alaska Native? Get Ready For Electronic Health Record Modernization With General Dynamics’ EHR Project
General Dynamics Corporation (NYSE: GD) was awarded a $2.5 billion indefinite-delivery, indefinite-quantity (IDIQ) contract by the Indian Health Service (IHS) to modernize its electronic health record (EHR) system